WallStreetZenWallStreetZen

NASDAQ: CSTL
Castle Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CSTL

Based on 3 analysts offering 12 month price targets for Castle Biosciences Inc.
Min Forecast
$25.00+32.7%
Avg Forecast
$30.00+59.24%
Max Forecast
$37.00+96.39%

Should I buy or sell CSTL stock?

Based on 3 analysts offering ratings for Castle Biosciences Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CSTL stock forecasts and price targets.

CSTL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-01Find Out Why
lockedlocked$00.00+00.00%2024-03-01
lockedlocked$00.00+00.00%2023-12-14

1 of 1

Forecast return on equity

Is CSTL forecast to generate an efficient return?
Company
N/A
Industry
8.11%
Market
29.39%

Forecast return on assets

Is CSTL forecast to generate an efficient return on assets?
Company
N/A
Industry
3.12%

CSTL revenue forecast

What is CSTL's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$237.5M+8.05%
Avg 2 year Forecast
$259.7M+18.15%
CSTL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CSTL revenue growth forecast

How is CSTL forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
8.05%
Industry
2.42%
Market
13.66%
CSTL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CSTL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CSTL vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
CSTL$18.84$30.00+59.24%Strong Buy
FLGT$20.09$30.00+49.33%Hold
CDNA$8.28$15.00+81.16%Strong Buy
SERA$9.68N/AN/A
LAB$2.61$3.38+29.31%Strong Buy
View Top Diagnostic & Research Stocks

Castle Biosciences Stock Forecast FAQ

Is Castle Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CSTL) stock is to Strong Buy CSTL stock.

Out of 3 analysts, 2 (66.67%) are recommending CSTL as a Strong Buy, 1 (33.33%) are recommending CSTL as a Buy, 0 (0%) are recommending CSTL as a Hold, 0 (0%) are recommending CSTL as a Sell, and 0 (0%) are recommending CSTL as a Strong Sell.

If you're new to stock investing, here's how to buy Castle Biosciences stock.

What is CSTL's revenue growth forecast for 2024-2025?

(NASDAQ: CSTL) Castle Biosciences's forecast annual revenue growth rate of 8.05% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.66%.

Castle Biosciences's revenue in 2024 is $219,788,000.On average, 1 Wall Street analysts forecast CSTL's revenue for 2024 to be $6,518,821,963, with the lowest CSTL revenue forecast at $6,518,821,963, and the highest CSTL revenue forecast at $6,518,821,963.

In 2025, CSTL is forecast to generate $7,128,486,085 in revenue, with the lowest revenue forecast at $7,119,976,591 and the highest revenue forecast at $7,136,995,580.

What is CSTL's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: CSTL) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 3.12%.

What is CSTL's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CSTL price target, the average CSTL price target is $30.00, with the highest CSTL stock price forecast at $37.00 and the lowest CSTL stock price forecast at $25.00.

On average, Wall Street analysts predict that Castle Biosciences's share price could reach $30.00 by Mar 1, 2025. The average Castle Biosciences stock price prediction forecasts a potential upside of 59.24% from the current CSTL share price of $18.84.

What is CSTL's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: CSTL) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.